We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

65 hedge funds and large institutions have $13M invested in Precision BioSciences in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

10% more capital invested

Capital invested by funds: $11.8M → $13M (+$1.14M)

0.03% less ownership

Funds ownership: 1% → 0.97% (-0.03%)

14% less funds holding

Funds holding: 76 → 65 (-11)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
65
Holders Change
-11
Holders Change %
-14.47%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
21
Reduced
10
Closed
15
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$1.22M
2
Renaissance Technologies
Renaissance Technologies
New York
+$359K
3
BOCH
Blue Owl Capital Holdings
New York
+$218K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$180K
5
Morgan Stanley
Morgan Stanley
New York
+$158K

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$573K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$486K
3
UOC
UBS O'Connor
Illinois
-$395K
4
Marshall Wace
Marshall Wace
United Kingdom
-$140K
5
JP Morgan Chase
JP Morgan Chase
New York
-$61.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$78.3K +$7.3K +677 +10%
RWMG
27
Redwood Wealth Management Group
New Jersey
$77.6K +$5.64K +523 +8%
Northern Trust
28
Northern Trust
Illinois
$57.3K – – –
HCA
29
Harbor Capital Advisors
Illinois
$54.7K +$6.16K +571 +13%
AF
30
Allworth Financial
California
$52.2K – – –
VC
31
Vivo Capital
California
$51.2K – – –
CAPTRUST Financial Advisors
32
CAPTRUST Financial Advisors
North Carolina
$41.4K -$3.17K -294 -7%
WMSA
33
Weiss Multi-Strategy Advisers
New York
$39K – – –
ACH
34
ArrowMark Colorado Holdings
Colorado
$34.6K -$1.6K -148 -4%
UBS Group
35
UBS Group
Switzerland
$32.4K +$3.23K +300 +11%
FCBT
36
First Citizens Bank & Trust
North Carolina
$31K – – –
Prudential Financial
37
Prudential Financial
New Jersey
$30.1K +$3.31K +307 +13%
HLA
38
Hamilton Lane Advisors
Pennsylvania
$28.9K – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$21.8K – – –
Franklin Resources
40
Franklin Resources
California
$20.8K – – –
FVWA
41
Foster Victor Wealth Advisors
South Carolina
$18.4K – – –
Citigroup
42
Citigroup
New York
$17K – – –
Osaic Holdings
43
Osaic Holdings
Arizona
$16.3K +$3.4K +315 +27%
EGM
44
Engineers Gate Manager
New York
$11.2K – – –
Pathstone Holdings
45
Pathstone Holdings
New Jersey
$9.94K +$9.79K +908 New
Bank of New York Mellon
46
Bank of New York Mellon
New York
$9.26K – – –
N
47
Natixis
France
$8.8K -$75 -7 -0.9%
LPL Financial
48
LPL Financial
California
$6.81K -$9.13K -847 -58%
HSA
49
HBK Sorce Advisory
Pennsylvania
$4.93K – – –
6F
50
626 Financial
Michigan
$4.81K – – –
1
2
3 4

DTIL Hedge Fund Activity: Q4 2023 in Review

65 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2023, worth a combined $13M — up 9.7% from $11.8M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of DTIL and 8 opened new positions — a net loss of 7 holders — while 10 trimmed existing stakes and 21 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $1.22M. The largest seller was Capital World Investors, cutting an estimated $573K.

  • 65 institutional investors held Precision BioSciences (DTIL) as of Q4 2023, down from 76 in Q3 2023.
  • Funds reported $13M of Precision BioSciences stock for Q4 2023, up 9.7% quarter-over-quarter.
  • 8 funds opened new Precision BioSciences positions in Q4 2023 and 15 closed out, a net change of -7 holders.
  • The largest Precision BioSciences buyer in Q4 2023 was Tang Capital Management, an estimated $1.22M added.
  • The largest Precision BioSciences seller in Q4 2023 was Capital World Investors, an estimated $573K sold.

Based on aggregated 13F filings for Q4 2023.